Previous 10 | Next 10 |
Kala Pharmaceuticals ( KALA ) announced that it had achieved positive results from its phase 3 study using EYSUVIS for the treatment of patients with dry eye disease. It had trouble in the past with its first NDA of this drug, because it had received a CRL. Now that the biotech has been ...
InsiderInsights' Daily Round-Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
Tiziana Life Sciences PLC (NASDAQ: TLSA ) +162% on potential coronavirus treatment . More news on: Tiziana Life Sciences PLC, Phio Pharmaceuticals Corp., Inovio Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Kala Pharmaceuticals (NASDAQ: KALA ) has priced its public offering of 16M common shares at $7.89 per share, for gross proceeds of ~$126.2M. More news on: Kala Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Kala Pharmaceuticals, Inc. (“Kala”) (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, announced today the pricing of an underwritten public offering of 16,000,000 shares of its ...
Kala Pharmaceuticals, Inc. (“Kala”) (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, announced today that it has commenced an underwritten public offering of $100.0 million of ...
Gainers: Spherix (NASDAQ: SPEX ) +146% . More news on: Spherix Incorporated, AIM ImmunoTech Inc., LightPath Technologies, Inc., Stocks on the move, , Read more ...
Spherix (NASDAQ: SPEX ) +72% . More news on: Spherix Incorporated, AIM ImmunoTech Inc., Cocrystal Pharma, Inc., Stocks on the move, , Read more ...
Kala Pharmaceuticals (NASDAQ: KALA ) is up 13% premarket on light volume in reaction to its announcement that a Phase 3 clinical trial, STRIDE 3 , evaluating lead candidate KPI-121 in patients with dry eye disease. More news on: Kala Pharmaceuticals, Inc., Healthcare stocks ...
News, Short Squeeze, Breakout and More Instantly...
Kala Pharmaceuticals Inc. Company Name:
KALA Stock Symbol:
NASDAQ Market:
Kala Pharmaceuticals Inc. Website:
2024-07-27 11:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 30.9% to $0.6 on volume of 558,931,853 shares NVIDIA Corporation (NVDA) fell 1.9% to $123.99 on volume of 249,243,816 shares Assure Holdings Corp. (IONM) rose 82.8% to $0.424 on vol...
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) is one of today's top gainers. The company's shares have moved 44.91% on the day to $6.55. Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus pe...